Research Breakthrough: IL-17 Blockers May Revolutionize the Treatment of Alopecia Areata
IL-17 blockers may revolutionize the treatment of alopecia areata. August is hair loss awareness month.
Tag: alopecia
All
PopularAll
Latest
Bempikibart Shows Sustained Hair Regrowth in Alopecia Areata
Phase 2a trial data presented at AAD 2025 show bempikibart leads to sustained hair regrowth in severe alopecia areata, demonstrating for the first time an IL-7Rα antagonist approach.
All
Latest
Integrating GLP-1s into Aesthetic Practice: Dr Johnny Franco on Personalizing the Patient Journey
Plastic surgeon Johnny Franco, MD, discusses how his firsthand experience with GLP-1s shaped his patient-centered wellness program and what plastic surgeons should know before adding similar treatments to their aesthetic practices.
Alopecia Patients May Be At Increased Risk of Heart Attack
NEW YORK (Reuters Health) – Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea.
Read More
REVIAN RED Wins 2020 MedTech Breakthrough Award for Best New Dermatology Solution
The REVIAN RED hair growth system was selected to receive a MedTech Breakthrough Award in the category “Best New Dermatology Technology Solution,” REVIAN Inc announces.
Read More
Clinical Trial Results of REVIAN RED Hair Loss Treatment Presented at Conference
Final data from a randomized, double-blind study of the REVIAN RED hair growth system was presented at the 2020 Winter Clinical Dermatology Conference – Hawaii, REVIAN announces.
Read More
Rep. Ayanna Pressley Says She Lives with Alopecia, Reveals Herself Without Hair
The Massachusetts congresswoman has come forward to reveal a more vulnerable side of her life and gets candid about a condition she shares with many others, the Grio writes.
Read More
Chemotherapy-Induced Alopecia Knowledge and Practice Gaps Occur Across Multiple Disciplines, Study Reveals
Results of a survey study examining awareness and attitudes of health care providers regarding permanent chemotherapy-induced alopecia (PCIA) revealed that dermatologists were more familiar with this condition than either oncology or primary care/internal medicine providers. The findings from this study were published in Supportive Care in Cancer, according to Oncology Nurse Advisor.
Read More
REVIAN RED Light Therapy Safe and Effective for Hair Growth, Study Results Suggest
Clinical trial results suggest favorable results from REVIAN RED light therapy to stop hair loss and subsequently grow new hair.
Read More
Adults with Alopecia May Have Higher Risk for Depression and Anxiety
Adult patients with alopecia areata and those with more severe hair loss may have an increased risk for anxiety and depression, suggest researchers from Massachusetts General Hospital in Boston.
Read More
Cyclosporin Is Moderately Effective for Alopecia, Study Notes
Cyclosporin is moderately effective for improving symptoms in patients with moderate to severe alopecia areata and may be considered as a second-line treatment for patients who fail to respond to corticosteroids, according to a study published in the Journal of the American Academy of Dermatology.
Read MoreThe Differential Diagnosis & Treatment of Female Hair Loss: August is National Hair Loss Awareness Month
Hair loss is not just a man’s problem. It happens to women, too. In this August 2015 issue feature, Jeffrey Epstein, MD, FACS, and Gorana Kukla, MD, discuss potential causes, as well as treatments, of female hair loss.
Read More